A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation

Drug and Alcohol Dependence

Volumn 102, Issue 1-3, 2009, Pages 116-122

  Parsons, Amanda ^a   Ingram, Jackie ^a   Inglis, Jennie ^a   Aveyard, Paul ^a   Johnstone, Elaine ^b   Brown, Karen ^b   Franklin, Mike ^c   Bermudez, Isabel ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Antidepressants; Food supplements; RCT; Smoking cessation; Weight gain

Indexed keywords

CHROMIUM; HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ABSENCE OF SIDE EFFECTS; ABSTINENCE; ADULT; AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FACTORIAL DESIGN; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MOOD CHANGE; NAUSEA; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT INDICATION; VOMITING; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADULT; ANXIETY; CHROMIUM COMPOUNDS; DEPRESSION; DIETARY SUPPLEMENTS; EDUCATION; ENDPOINT DETERMINATION; ETHNIC GROUPS; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; SUBSTANCE WITHDRAWAL SYNDROME; WEIGHT GAIN;

NICOTIANA TABACUM;

EID: 64949154997     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.02.006     Document Type: Article

References (39)

1. Alexander R., Ladislav S., Nitsa M., and Richard A.A. Control of steroid-induced diabetes with supplemental chromium. J. Trace Elem. Exp. Med. 12 (1999) 375-378
2. Assali A.R., Beigel Y., Schreibman R., Shafer Z., and Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clin. Cardiol. 22 (1999) 357-360
3. Attenburrow M.J., Odontiadis J., Murray B.J., Cowen P.J., and Franklin M. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology (Berl.) 159 (2002) 432-436
4. Barnes J., Barber N., Wheatley D., and Williamson E.M. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's Wort (Hypericum perforatum) herb extract (LI-60) as an ais to motivation/behavioural support in smoking cessation. Planta Med. 72 (2006) 378-382
5. Becker, B., Bock, B., 2003. St. John's Wort oral spray reduces withdrawal symptoms during quitting smoking (POS4-82).
6. Borrelli B., Spring B., Niaura R., Kristeller J., and Keuthen N.J. Weight supression and weight rebound in ex-smokers treated with fluoxetine. J. Consult. Clin. Psychol. 67 (1999) 124-131
7. Catania M.A., Firenzuoli F., Crupi A., Mannucci C., Caputi A.P., and Calapai G. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology (Berl.) 169 (2003) 186-189
8. Covey L.S., Glassman A.H., Stetner F., Rivelli S., and Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am. J. Psychiatry 159 (2002) 1731-1737
9. Davidson J.R., Abraham K., Connor K.M., and McLeod M.N. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol. Psychiatry 53 (2003) 261-264
10. Fava M., Alpert J., Nierenberg A., and Mischoulon D. A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J. Clin. Psychopharmacol. 25 (2005) 441-447
11. Franklin M., Chi J., McGavin C., Hockney R., Reed A., Campling G., Whale R.W., and Cowen P.J. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol. Psychiatry 46 (1999) 581-584
12. Franklin M., and Odontiadis J. Chromium a potential antidepressant: a study of its pharmacology in the rat. World J. Biol. Psychiatry 5 (2004) 127
13. Froom P., Melamed S., and Benbassat J. Smoking cessation and weight gain. J. Fam. Pract. 46 (1998) 460-464
14. International Conference on Harmonisation Good Clinical Practice. http://www.ich.org/cache/compo/276-254-1.html. 2008; 29-12-2008.
15. Goodall E., Cowen P., Franklin M., and Silverstone T. Ritanserin attenuates anorectic, endocrine and thermic responses tod-fenfluramine in human volunteers. Psychopharmacology (Berl.) 112 (1993) 461-466
16. Guerrero-Romero F., and Rodriguez-Moran M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch. Med. Res. 36 (2005) 250-257
17. Hajek P. Withdrawal-oriented therapy for smokers. Br. J. Addict. 84 (1989) 591-598
18. Hughes J.R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tobacco Res. 9 (2007) 315-327
19. Hughes J.R., Keely J., and Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99 (2004) 29-38
20. Hughes J.R., Keely J.P., Niaura R.S., Ossip-Klein D.J., Richmond R.L., and Swan G.E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tobacco Res. 5 (2003) 13-25
21. Hughes, J.R., Stead, L.F., Lancaster, T., 2007. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews: Reviews 2007 Issue 1. John Wiley & Sons, Ltd., Chichester, UK. doi:10.1002/14651858.CD000031 (pub3).
22. Lancaster, T., Stead, L.F., 2005. Individual behavioural counselling for smoking cessation. The Cochrane Database of Systematic Reviews: Reviews 2005 Issue 2. John Wiley & Sons, Ltd., Chichester, UK. doi:10.1002/14651858.CD001292 (pub2).
23. Lawvere S., Mahoney M.C., Cummings K.M., Kepner J.L., Hyland A., Lawrence D.D., and Murphy J.M. A Phase II study of St. John's Wort for smoking cessation. Complement Ther. Med. 14 (2006) 175-184
24. Linde, K., Berner, M.M., Kriston, L., 2008. St John's wort for major depression. Cochrane Database of Systematic Reviews 2008. Issue 4.
25. McCarty M.F. Chromium picolinate may favorably influence the vascular risk associated with smoking by combating cortisol-induced insulin resistance. Med. Hypotheses 64 (2005) 1220-1224
26. Parsons, A.C., Shraim, M., Inglis, J., Aveyard, P., Hajek, P. Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006219. doi:10.1002/14651858.CD006219.pub2.
27. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J. Abnorm. Psychol. 112 (2003) 3-13
28. Pittler M.H., Stevinson C., and Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int. J. Obesity Relat. Metab. Disorders: J. Int. Assoc. Study Obesity (2003) 522-529
29. Shiffman S., West R.J., and Gilbert D.G. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tobacco Res. 6 (2004) 599-614
30. Stead, L.F., Perera, R., Bullen, C., Mant, D., Lancaster, T., 2008. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews: Reviews 2008 Issue 1. John Wiley & Sons, Ltd., Chichester, UK. doi:10.1002/14651858.CD000146 (pub3).
31. Szegedi A., Kohnen R., Dienel A., and Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330 (2005) 503
32. Uzbay T.I. Hypericum perforatum and substance dependence: a review. Phytother. Res. 22 (2008) 578-582
33. Vincent J.B. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 33 (2003) 213-230
34. West, R., 2006. Smoking and Smoking Cessation in England. http://aspsilverbackwebsites.co.uk/smokinginengland/Ref/paper4.pdf, pp. 1-4.
35. West R. The clinical significance of 'small' effects of smoking cessation treatments. Addiction 102 (2007) 506-509
36. West R., Hajek P., Stead L., and Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 100 (2005) 299-303
37. West R., and Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology (Berl.) 155 (2001) 115-122
38. West R., and Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl.) 177 (2004) 195-199
39. Zhou S., Chan E., Pan S.Q., Huang M., and Lee E.J. Pharmacokinetic interactions of drugs with St John's wort. [Review] [153 refs]. J. Psychopharmacol. (Oxf.) 18 (2004) 262-276